PCV34 Cost-Offset Analysis of Dapagliflozin in Treating Heart Failure with Reduced Ejection Fraction (HFREF) in China
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.374
https://www.valueinhealthjournal.com/article/S1098-3015(21)00591-X/fulltext
Title :
PCV34 Cost-Offset Analysis of Dapagliflozin in Treating Heart Failure with Reduced Ejection Fraction (HFREF) in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00591-X&doi=10.1016/j.jval.2021.04.374
First page :
Section Title :
Open access? :
No
Section Order :
10947